Osamu Iizuka

Osamu started Medmain to develop and provide Pathology AI Analysis Solution called "PidPort.” PidPort is a product that enables the presentation of highly accurate and rapid analysis results by pathological AI developed through deep learning, and enables online pathological diagnosis such as telepathology.

There is a global shortage of pathologists who observe patients’ tissues and cells to determine the presence of cancer and the treatment process, resulting in serious delays in pathological diagnosis. With “PidPort,” we aim to create a society where everyone can attain immediate high standard pathological diagnosis.